Literature DB >> 24857590

Generation and characterization of an immortalized human mesenchymal stromal cell line.

Magne Skårn1, Paul Noordhuis, Meng-Yu Wang, Marjan Veuger, Stine Henrichson Kresse, Eivind Valen Egeland, Francesca Micci, Heidi Maria Namløs, Anne-Mari Håkelien, Solveig Mjelstad Olafsrud, Susanne Lorenz, Guttorm Haraldsen, Gunnar Kvalheim, Leonardo Andrés Meza-Zepeda, Ola Myklebost.   

Abstract

Human mesenchymal stromal cells (hMSCs) show great potential for clinical and experimental use due to their capacity to self-renew and differentiate into multiple mesenchymal lineages. However, disadvantages of primary cultures of hMSCs are the limited in vitro lifespan, and the variable properties of cells from different donors and over time in culture. In this article, we describe the generation of a telomerase-immortalized nontumorigenic human bone marrow-derived stromal mesenchymal cell line, and its detailed characterization after long-term culturing (up to 155 population doublings). The resulting cell line, iMSC#3, maintained a fibroblast-like phenotype comparable to early passages of primary hMSCs, and showed no major differences from hMSCs regarding surface marker expression. Furthermore, iMSC#3 had a normal karyotype, and high-resolution array comparative genomic hybridization confirmed normal copy numbers. The gene expression profiles of immortalized and primary hMSCs were also similar, whereas the corresponding DNA methylation profiles were more diverse. The cells also had proliferation characteristics comparable to primary hMSCs and maintained the capacity to differentiate into osteoblasts and adipocytes. A detailed characterization of the mRNA and microRNA transcriptomes during adipocyte differentiation also showed that the iMSC#3 recapitulates this process at the molecular level. In summary, the immortalized mesenchymal cells represent a valuable model system that can be used for studies of candidate genes and their role in differentiation or oncogenic transformation, and basic studies of mesenchymal biology.

Entities:  

Mesh:

Year:  2014        PMID: 24857590      PMCID: PMC4172386          DOI: 10.1089/scd.2013.0599

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  47 in total

1.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

Authors:  Pieternella S in 't Anker; Willy A Noort; Sicco A Scherjon; Carin Kleijburg-van der Keur; Alwine B Kruisselbrink; Rutger L van Bezooijen; Willem Beekhuizen; Roelof Willemze; Humphrey H H Kanhai; Willem E Fibbe
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

2.  Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture.

Authors:  Andrew C Boquest; Aboulghassem Shahdadfar; Katrine Frønsdal; Olafur Sigurjonsson; Siv H Tunheim; Philippe Collas; Jan E Brinchmann
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

3.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

Authors:  T Honma; O Honmou; S Iihoshi; K Harada; K Houkin; H Hamada; J D Kocsis
Journal:  Exp Neurol       Date:  2005-06-20       Impact factor: 5.330

4.  Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation.

Authors:  Ling Wu; Jeroen C H Leijten; Nicole Georgi; Janine N Post; Clemens A van Blitterswijk; Marcel Karperien
Journal:  Tissue Eng Part A       Date:  2011-02-28       Impact factor: 3.845

5.  Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.

Authors:  Basem M Abdallah; Mandana Haack-Sørensen; Jorge S Burns; Birgitte Elsnab; Franz Jakob; Peter Hokland; Moustapha Kassem
Journal:  Biochem Biophys Res Commun       Date:  2005-01-21       Impact factor: 3.575

6.  Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device.

Authors:  Ellen Tenstad; Anna Tourovskaia; Albert Folch; Ola Myklebost; Edith Rian
Journal:  Lab Chip       Date:  2010-03-09       Impact factor: 6.799

7.  Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.

Authors:  Bing Yang; Sean O'Herrin; Jianqiang Wu; Shannon Reagan-Shaw; Yongsheng Ma; Minakshi Nihal; B Jack Longley
Journal:  J Invest Dermatol       Date:  2006-09-07       Impact factor: 8.551

8.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

Authors:  Janne L Simonsen; Cecilia Rosada; Nedime Serakinci; Jeannette Justesen; Karin Stenderup; Suresh I S Rattan; Thomas G Jensen; Moustapha Kassem
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

9.  Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression.

Authors:  Tong Ming Liu; Wei Ming Ng; Hwee San Tan; Denslin Vinitha; Zheng Yang; Jia Bing Fan; Yu Zou; James H Hui; Eng Hin Lee; Bing Lim
Journal:  Stem Cells Dev       Date:  2012-08-21       Impact factor: 3.272

10.  miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1.

Authors:  Hasse Brønnum; Ditte C Andersen; Mikael Schneider; Maria B Sandberg; Tilde Eskildsen; Solveig B Nielsen; Raghu Kalluri; Søren P Sheikh
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more
  19 in total

1.  Coculturing Human Islets with Proangiogenic Support Cells to Improve Islet Revascularization at the Subcutaneous Transplantation Site.

Authors:  Mijke Buitinga; Karolina Janeczek Portalska; Dirk-Jan Cornelissen; Jacqueline Plass; Maaike Hanegraaf; Françoise Carlotti; Eelco de Koning; Marten Engelse; Clemens van Blitterswijk; Marcel Karperien; Aart van Apeldoorn; Jan de Boer
Journal:  Tissue Eng Part A       Date:  2016-01-27       Impact factor: 3.845

2.  Kinship of conditionally immortalized cells derived from fetal bone to human bone-derived mesenchymal stroma cells.

Authors:  S Marozin; B Simon-Nobbe; S Irausek; L W K Chung; G Lepperdinger
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

3.  Development of a biologically immortalized equine stem cell line.

Authors:  Rodolfo Nino-Fong; Blanca P Esparza Gonzalez; Juan Carlos Rodriguez-Lecompte; William Montelpare; Laurie McDuffee
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

4.  Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.

Authors:  Elin Hallan Naderi; Seham Skah; Hege Ugland; Ola Myklebost; Dagny Lise Sandnes; Maria Lyngaas Torgersen; Dag Josefsen; Ellen Ruud; Soheil Naderi; Heidi Kiil Blomhoff
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

5.  Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma.

Authors:  Robert Hanes; Iwona Grad; Susanne Lorenz; Eva W Stratford; Else Munthe; Chilamakuri Chandra Sekhar Reddy; Leonardo A Meza-Zepeda; Ola Myklebost
Journal:  Oncotarget       Date:  2016-08-23

6.  Immortalizing Mesenchymal Stromal Cells from Aged Donors While Keeping Their Essential Features.

Authors:  María Piñeiro-Ramil; Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; Silvia Rodríguez-Fernández; Tamara Hermida-Gómez; Francisco J Blanco-García; Isaac Fuentes-Boquete; Silvia Díaz-Prado
Journal:  Stem Cells Int       Date:  2020-06-16       Impact factor: 5.443

7.  Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma.

Authors:  Robert Hanes; Else Munthe; Iwona Grad; Jianhua Han; Ida Karlsen; Emmet McCormack; Leonardo A Meza-Zepeda; Eva Wessel Stratford; Ola Myklebost
Journal:  Cells       Date:  2019-02-21       Impact factor: 6.600

8.  Usefulness of Mesenchymal Cell Lines for Bone and Cartilage Regeneration Research.

Authors:  M Piñeiro-Ramil; C Sanjurjo-Rodríguez; R Castro-Viñuelas; S Rodríguez-Fernández; I M Fuentes-Boquete; F J Blanco; S M Díaz-Prado
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

9.  Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.

Authors:  Susanne Lorenz; Tale Barøy; Jinchang Sun; Torfinn Nome; Daniel Vodák; Jan-Christian Bryne; Anne-Mari Håkelien; Lynnette Fernandez-Cuesta; Birte Möhlendick; Harald Rieder; Karoly Szuhai; Olga Zaikova; Terje C Ahlquist; Gard O S Thomassen; Rolf I Skotheim; Ragnhild A Lothe; Patrick S Tarpey; Peter Campbell; Adrienne Flanagan; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  Oncotarget       Date:  2016-02-02

10.  Molecular Phenotyping of Telomerized Human Bone Marrow Skeletal Stem Cells Reveals a Genetic Program of Enhanced Proliferation and Maintenance of Differentiation Responses.

Authors:  Natalie A Twine; Linda Harkness; James Adjaye; Abdullah Aldahmash; Marc R Wilkins; Moustapha Kassem
Journal:  JBMR Plus       Date:  2018-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.